reference/34041810

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34041810

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	2490
issn	1525-0016
issueIdentifier	7
pageRange	2474-2490
publicationName	Molecular therapy : the journal of the American Society of Gene Therapy
startingPage	2474
bibliographicCitation	Musardo S, Therin S, Pelucchi S, D’Andrea L, Stringhi R, Ribeiro A, Manca A, Balducci C, Pagano J, Sala C, Verpelli C, Grieco V, Edefonti V, Forloni G, Gardoni F, Meli G, Di Marino D, Di Luca M, Marcello E. The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer’s disease. Molecular Therapy. 2022 Jul;30(7):2474–90. doi: 10.1016/j.ymthe.2022.03.024.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2643bf1f8618f401009e0c93c27d5a45 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0392-0905 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d54f0195b88d9fd1ca2855db96851c03 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b06e99f4450ebe496299cd4c341a8449 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2949-9725 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b36855052726626b64d9f504cd805d7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_57bca35eb0e9000b5939a1b0ce88d5e2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9445-4235 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4633-364X http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1995-1477 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_84100aa97124b16f145d047c2c3500bc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a53397d0c7f0f0be2f45103d08cf216d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a0ee3880f1a9f533272d7dc16f66c482 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9c3ca67231780fae567a23a1a489cbad http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5374-3914 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5268-7957 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7cc2f110e1dc0b13ebebed66c546c16e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_010def68788e1210490e5549c7d5a9d4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0452-762X http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0662-9523
date	2022-07-06^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1016/j.ymthe.2022.03.024 https://pubmed.ncbi.nlm.nih.gov/35390543 https://pubmed.ncbi.nlm.nih.gov/PMC9263258
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21793 https://portal.issn.org/resource/ISSN/1525-0016
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer’s disease
discusses	http://id.nlm.nih.gov/mesh/M000616517 http://id.nlm.nih.gov/mesh/M0013341 http://id.nlm.nih.gov/mesh/M0205216 http://id.nlm.nih.gov/mesh/M0025265 http://id.nlm.nih.gov/mesh/M0473346
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000544Q000378 http://id.nlm.nih.gov/mesh/D000544Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D004705 http://id.nlm.nih.gov/mesh/D016564Q000378 http://id.nlm.nih.gov/mesh/D008565Q000378 http://id.nlm.nih.gov/mesh/D053829Q000235 http://id.nlm.nih.gov/mesh/D013569Q000378 http://id.nlm.nih.gov/mesh/D000072197Q000378 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D008565Q000235 http://id.nlm.nih.gov/mesh/D008822 http://id.nlm.nih.gov/mesh/D000072197Q000235 http://id.nlm.nih.gov/mesh/D004195
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9523 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ba6e049b9ca0c8937df48865edec427c http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7de983648792acc718ff12a75a09df02 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_26affd5ccc17d1026ea8e56bb3df26c8

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11487

Showing number of triples: 1 to 63 of 63.